- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02442869
Developing Adaptive Interventions for Suicidal College Students Seeking Treatment - SMART (SMART)
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Nevada
-
Reno, Nevada, United States, 89557
- Counseling Services, University of Nevada, Reno
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Enrolled student at the University of Nevada, Reno (UNR)
- Seeking services at Counseling Services at UNR
- 18 to 25 years of age
- Moderate to severe suicidality (indicated by a score of 2 or above (range is 0 "not at all like me" to 4 "extremely like me") on the Counseling Center Assessment of Psychological Symptoms (CCAPS-34; Locke et al., 2012) question, "I have thoughts of ending my life."
Exclusion Criteria:
- Individual is deemed inappropriate to receive services at UNR Counseling Services by the intake worker (the primary exclusion criterion).
- Participant cannot have been in treatment at UNR Counseling Services within the previous 3 months.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Stage 1 TAU plus Stage 2 CAMS
Treatment as usual [TAU] -- the treatment typically provided by the counselor for 4-8 weeks If participant is responding, treatment ends. Participants who don't respond are then re-randomized to Collaborative Assessment and Management of Suicidality (CAMS) for 4-16 weeks |
4-8 weeks of the treatment typically provided by that counselor with the caveat that neither DBT nor CAMS can be provided.
4-16 weeks of Collaborative Assessment and Management of Suicidality (CAMS)
|
|
Experimental: Stage 1 TAU plus Stage 2 DBT
Treatment as usual [TAU] -- the treatment typically provided by the counselor for 4-8 weeks If participant is responding, treatment ends. Participants who don't respond are then re-randomized to Dialectical Behavioral Therapy (DBT) for 4-16 weeks |
4-8 weeks of the treatment typically provided by that counselor with the caveat that neither DBT nor CAMS can be provided.
4-16 weeks of Dialectical Behavioral Therapy (DBT)
|
|
Experimental: Stage 1 CAMS plus Stage 2 CAMS
Collaborative Assessment and Management of Suicidality (CAMS) for 4-8 weeks If participant is responding, treatment ends. Participants who don't respond are then re-randomized to Additional Collaborative Assessment and Management of Suicidality (CAMS) for 4-16 weeks |
4-16 weeks of Collaborative Assessment and Management of Suicidality (CAMS)
4-8 weeks of Collaborative Assessment and Management of Suicidality (CAMS)
|
|
Experimental: Stage 1 CAMS plus Stage 2 DBT
Collaborative Assessment and Management of Suicidality (CAMS) for 4-8 weeks If participant is responding, treatment ends. Participants who don't respond are then re-randomized to Dialectical Behavioral Therapy (DBT) for 4-16 weeks |
4-16 weeks of Dialectical Behavioral Therapy (DBT)
4-8 weeks of Collaborative Assessment and Management of Suicidality (CAMS)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility/Acceptability: Participation Rate
Time Frame: Baseline
|
Number of students approached who agreed to participate in the study
|
Baseline
|
|
Feasibility/Acceptability: Number of Students Who Declined to Participate in the Study and Why
Time Frame: Baseline
|
Two typologies as to when students declined to participate emerged: Declined when approached, and Declined during the consenting process.
|
Baseline
|
|
Feasibility/Acceptability: Number of Students Who Were Retained Within Each of the Four Adaptive Treatment Strategies
Time Frame: After Stage 2
|
Feasibility/Acceptability (Treatment Retention): Number of students who were retained within each of the four Adaptive Treatment Strategies
|
After Stage 2
|
|
Feasibility/Acceptability: General Time to Drop-out Among Students Who Dropped Out Within Each Arm
Time Frame: Throughout the 24 weeks of treatment delivery (Stage 1 and Stage 2)
|
General time to drop out among students who dropped out within each arm, by number of treatment sessions received
|
Throughout the 24 weeks of treatment delivery (Stage 1 and Stage 2)
|
|
Feasibility/Acceptability: Fidelity of the CAMS Intervention Delivery by "Real World" CCC Counselors Via the CAMS Rating Scale 3 (CRS.3)
Time Frame: Throughout the 24 weeks of treatment delivery (Stage 1 and Stage 2)
|
CAMS adherence ratings conducted by CAMS experts.
The CAMS Rating Scale (CRS.3) was used to assess CAMS adherence.
The CRS.3 has 14 items rated on a 7-point scale from 0 (Poor) to 6 (Excellent).
Therefore, higher scores indicate better adherence.
Adherence covers various domains: collaboration (4 items), suicide focus (1 item), risk assessment (1 item), treatment planning (3 items), intervention (2 items), and overall adherence (1 item).
Two coders assessed the fidelity of CAMS by observing digitally recorded sessions.
|
Throughout the 24 weeks of treatment delivery (Stage 1 and Stage 2)
|
|
Feasibility/Acceptability: Fidelity of the DBT Intervention Delivery by "Real World" CCC Counselors Via the University of Washington DBT Adherence Rating Scale (Linehan & Korslund, 2003)
Time Frame: During Stage 2 (sessions 9 through 24 of treatment)
|
DBT adherence ratings conducted by DBT adherence experts.
The University of Washington Dialectical Behavior Therapy Adherence Coding Scale (DBTACS) was utilized to check DBT adherence.
The DBTACS has various dimensions, each measured on a 5-point scale (ranging from 0.0-5.0, with 5 indicating greater adherence).
Therefore, higher scores indicate better adherence.
The overall score is an average of these dimensions with a cutoff of 4.0 for adherence.
|
During Stage 2 (sessions 9 through 24 of treatment)
|
|
Feasibility/Acceptability: Satisfaction With Treatment as Reported by Student Participants Via the the Client Satisfaction Questionnaire (CSQ-8)
Time Frame: End of Stage 1 (after 8 weeks of treatment) and end of Stage 2 (after 24 weeks of treatment)
|
The Client Satisfaction Questionnaire (CSQ-8) assesses client satisfaction with treatment on a scale from 8-32, with higher scores indicating greater satisfaction.
Low satisfaction ratings (CSQ score of 8-20); Medium satisfaction ratings (CSQ score of 21-26); High satisfaction ratings (CSQ score of 27-32).
|
End of Stage 1 (after 8 weeks of treatment) and end of Stage 2 (after 24 weeks of treatment)
|
|
Feasibility/Acceptability: Satisfaction With Treatment by Counselors Via the CSQ-8 (Therapist Version)
Time Frame: End of Stage 1 (after 8 weeks of treatment) and end of Stage 2 (after 24 weeks of treatment)
|
The Client Satisfaction Questionnaire (CSQ-8) Therapist Version assesses therapist satisfaction with treatment on a scale from 8-32, with higher scores indicating greater satisfaction.
Low satisfaction ratings (CSQT score of 8-20); Medium satisfaction ratings (CSQT score of 21-26); High satisfaction ratings (CSQT score of 27-32).
|
End of Stage 1 (after 8 weeks of treatment) and end of Stage 2 (after 24 weeks of treatment)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Scale for Suicide Ideation-Current (SSI)
Time Frame: End of Stage 1 interventions - ~8 weeks after baseline; End of Stage 2 interventions ~24 weeks after baseline; and Follow-up (3 months after all treatment has ended) ~36 weeks after baseline
|
The SSI is an interviewer-rated measure based on 19 questions related to the highest intensity of suicidal ideation in the past 2 weeks, including attitudes, behaviors, and plans.
Each item is rated as 0,1, or 2 and the total scale yields a score of 0-38.
Higher scores indicate greater suicide risk.
|
End of Stage 1 interventions - ~8 weeks after baseline; End of Stage 2 interventions ~24 weeks after baseline; and Follow-up (3 months after all treatment has ended) ~36 weeks after baseline
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Suicide Attempt and Self-Injury Count (SASI-C)
Time Frame: The time frame at pretreatment was both lifetime and past 2 months at baseline: and all other assessments focused on the last 2 months. This was assessed at baseline and after Stage 1 (~ 8 weeks later).
|
The SASI-C is a very brief interview of past self-inflicted injuries, categorized into suicide attempts and nonsuicidal acts.
The SASI-C creates counts of self-inflicted injuries by method, medical risk severity, and lethality.
|
The time frame at pretreatment was both lifetime and past 2 months at baseline: and all other assessments focused on the last 2 months. This was assessed at baseline and after Stage 1 (~ 8 weeks later).
|
|
The Counseling Center Assessment of Psychological Symptoms (CCAPS-34) Depression Scale.
Time Frame: Baseline and End of Stage 1 interventions - 8 weeks after baseline
|
The CCAPS-34 is a measure of psychological distress with several sub-scales (Depression) specifically designed for college students seeking services.
Depression subscale scores range from 0.1-5.0 with lower scores representing less depression
|
Baseline and End of Stage 1 interventions - 8 weeks after baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jacqueline Pistorello, PhD, University of Nevada, Reno
Publications and helpful links
General Publications
- Attkisson CC, Zwick R. The client satisfaction questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome. Eval Program Plann. 1982;5(3):233-7. doi: 10.1016/0149-7189(82)90074-x.
- Almirall D, Compton SN, Gunlicks-Stoessel M, Duan N, Murphy SA. Designing a pilot sequential multiple assignment randomized trial for developing an adaptive treatment strategy. Stat Med. 2012 Jul 30;31(17):1887-902. doi: 10.1002/sim.4512. Epub 2012 Mar 22.
- Arnett JJ. Emerging adulthood. A theory of development from the late teens through the twenties. Am Psychol. 2000 May;55(5):469-80.
- Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol. 1979 Apr;47(2):343-52. doi: 10.1037//0022-006x.47.2.343. No abstract available.
- Comtois KA, Jobes DA, S O'Connor S, Atkins DC, Janis K, E Chessen C, Landes SJ, Holen A, Yuodelis-Flores C. Collaborative assessment and management of suicidality (CAMS): feasibility trial for next-day appointment services. Depress Anxiety. 2011 Nov;28(11):963-72. doi: 10.1002/da.20895. Epub 2011 Sep 21.
- American College Health Association (ACHA, 2012). ACHA-National College Health Assessment II: Reference group executive summary Spring 2011. Hanover MD: American College Health Association.
- Center for Collegiate Mental Health (CCMH, 2012). CCAPS 2012 Technical Manual. University Park, PA.
- Jobes, D. A. (2006). Managing suicidal risk: A collaborative approach. New York: The Guilford Press.
- Linehan, M.M. (1993). Cognitive behavioral therapy of borderline personality disorder. New York: Guilford Press.
- Linehan, M.M. (2015). DBT skills training manual (2nd ed.). New York, NY: Guilford Press.
- Pistorello J, Jobes DA, Gallop R, Compton SN, Locey NS, Au JS, Noose SK, Walloch JC, Johnson J, Young M, Dickens Y, Chatham P, Jeffcoat T. A Randomized Controlled Trial of the Collaborative Assessment and Management of Suicidality (CAMS) Versus Treatment as Usual (TAU) for Suicidal College Students. Arch Suicide Res. 2021 Oct-Dec;25(4):765-789. doi: 10.1080/13811118.2020.1749742. Epub 2020 Apr 10.
- Pistorello J, Jobes DA, Compton SN, Locey NS, Walloch JC, Gallop R, Au JS, Noose SK, Young M, Johnson J, Dickens Y, Chatham P, Jeffcoat T, Dalto G, Goswami S. Developing Adaptive Treatment Strategies to Address Suicidal Risk in College Students: A Pilot Sequential, Multiple Assignment, Randomized Trial (SMART). Arch Suicide Res. 2017 Oct-Dec;22(4):644-664. doi: 10.1080/13811118.2017.1392915. Epub 2018 Feb 12.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 603856
- R34MH104714 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
- Researcher contacts PI at pistorel@unr.edu
- There is justification for the use of the data and this is deemed appropriate by the PI and institution representative
IPD Sharing Supporting Information Type
- SAP
- ICF
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Suicide
-
University of Sao PauloNot yet recruitingSuicide Ideation | Suicide Attempts
-
Dartmouth-Hitchcock Medical CenterNational Institute of Nursing Research (NINR); Trustees of Dartmouth CollegeNot yet recruitingSuicide Attempt | Suicide IdeationUnited States
-
University of North Carolina, Chapel HillVillage Heartbeat, Inc.RecruitingSuicide | Suicide Attempt | Suicide Ideation | Suicide PreventionUnited States
-
Fundació Institut de Recerca de l'Hospital de la...Not yet recruitingSuicide | Suicide Risk | Suicide Attempt | Suicide Ideation | Suicide PreventionSpain
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH); Robert Wood Johnson FoundationRecruitingSuicide | Suicide Attempt | Suicide Ideation | Suicide PreventionUnited States
-
VA Office of Research and DevelopmentRecruitingSuicide Attempt | Suicide Ideation | Suicide PreventionUnited States
-
Syeda AYAT E ZAINAB AliUniversity of Leicester; University of WuerzburgRecruitingSuicide, Attempted | Suicide | Suicide Prevention | Completed SuicidePakistan
-
Seattle Children's HospitalNationwide Children's HospitalRecruitingSuicidal Ideation | Suicide Threat | Suicide and Self-harm | Suicide AttemptsUnited States
-
Kaiser PermanenteNational Institute of Mental Health (NIMH); Henry Ford Health System; HealthPartners...Enrolling by invitationSuicide, Attempted | Suicide, FatalUnited States
-
University of ChicagoNational Institute of Mental Health (NIMH)RecruitingSuicidal Ideation | Suicide | Suicide AttemptUnited States
Clinical Trials on Stage 1 Treatment as usual (TAU)
-
Centro Mente Aberta de MindfulnessUnknown
-
Academisch Medisch Centrum - Universiteit van Amsterdam...KU Leuven; ZonMw: The Netherlands Organisation for Health Research and Development and other collaboratorsRecruiting
-
Hospital Universitari Vall d'Hebron Research InstituteParc Sanitari Sant Joan de Déu; Universitat Autonoma de BarcelonaCompleted
-
Centre for Addiction and Mental HealthCompleted
-
Nova Scotia Health AuthorityCompletedEating DisordersCanada
-
Virginia Commonwealth UniversityCompletedSubstance Use Disorders | Substance Abuse | Drug Abuse | Drug Addiction | Drug Dependence | Drug Use Disorders | Substance AddictionUnited States
-
University of BariUniversity of Dublin, Trinity CollegeCompletedRecovery | Mental Disorder | Schizophrenia and Related Disorders | Intellectual Disability, Mild to Moderate | Personality Disorders and Disturbances in Behavior | Personality Disorders, AntisocialItaly
-
Hospital Universitari Vall d'Hebron Research InstituteActive, not recruiting
-
Aalborg University HospitalRecruitingDepressive Disorder | Depression | Depressive Episode | Depressive Disorders | Depressive Episodes | Depression - Major Depressive Disorder | Depressive Disorder, Major Depressive DisorderDenmark
-
University of Wisconsin, MadisonMedical University of South Carolina; National Heart, Lung, and Blood Institute...Completed